Incidence of adverse reactions to vaccines in a paediatric population

Clinical Drug Investigation

Volumn 24, Issue 8, 2004, Pages 457-463

  Carrasco Garrido, Pilar ^a   Gallardo Pino, Carmen ^a   Jiménez García, Rodrigo ^a   Tapias, Miguel A ^a   Gil De Miguel, Ángel ^a  

^a UNIVERSIDAD REY JUAN CARLOS   (Spain)

Author keywords

[No Author keywords available]

Indexed keywords

DIPHTHERIA PERTUSSIS TETANUS VACCINE; HEPATITIS B VACCINE; MEASLES MUMPS RUBELLA VACCINE; MENINGOCOCCUS VACCINE; ORAL POLIOMYELITIS VACCINE;

ANESTHESIA (SENSORY DYSFUNCTION); CLINICAL TRIAL; DIARRHEA; DIPHTHERIA; DRUG SAFETY; EDEMA; EMERGENCY; FEVER; FOLLOW UP; HUMAN; INFLUENZA; INJECTION SITE; MEASLES; MUMPS; PAIN; PERTUSSIS; POPULATION RESEARCH; PRIORITY JOURNAL; RASH; REVIEW; RUBELLA; SIDE EFFECT; SOMNOLENCE; TELEPHONE; TETANUS; URTICARIA; VACCINATION; VOMITING;

EID: 4344577244     PISSN: 11732563     EISSN: None     Source Type: Journal    
DOI: 10.2165/00044011-200424080-00004     Document Type: Review

References (24)

1. Gellin B, Maibach E, Marcuse E. Do parents understand immunizations? A national telephone survey. Pediatrics 2000; 106 (5): 1097-102
2. Grabenstein JD, Wilson JP. Are vaccines safe? Risk communication applied to vaccination. Hosp Pharm 1999; 34 (6): 713-29
3. Nasir L. Reconnoitering the antivaccination web site: news from the front. J Fam Pract 2000; 49 (8): 731-3
4. Kimmel SR. Vaccine adverse events: separating myth from reality. Am Fam Physician 2002; 66 (11): 2113-20
5. Maldonado Y. Current controversies in vaccination: vaccine safety. JAMA 2002; 288 (24): 3155-8
6. Varricchio F, Iskander J, Destefano F, et al. Understanding vaccine safety information from the vaccine adverse event reporting system. Pediatr Infect Dis J 2004 Apr; 23 (4): 287-94
7. Batalla J, Parrón I, Boldú M, et al. Programa de sospecha de reacciones adversas a vacunas de Cataluña. Vacunas 2000; 1 (3): 119-25
8. Ellenberg S, Braun M. Monitoring the safety of vaccines: assessing the risks. Drug Saf 2002; 25 (3): 145-52
9. Smeeth L, Rodrigues LC, Hall AJ, et al. Evaluation of adverse effects of vaccines: the case-control approach. Vaccine 2002; 20: 2611-7
10. Halsey N. The science of evaluation of adverse events associated with vaccination. Semin Pediatr Infect Dis 2002; 13 (3): 205-14
11. Heijbel H, Jefferson T. Vaccine safety: improving monitoring. Vaccine 2001; 19: 2457-60
12. Salleras L. La seguridad de las vacunas. Vacunas 2003; 4: 18-21
13. Morales-Olivas FJ, Martinez-Mir I, Ferrer JM, et al. Adverse drug reactions in children reported by means of the yellow card in Spain. J Clin Epidemiol 2000 Oct; 53 (10): 1076-80
14. Ranganathan SS, Houghton JE, Davies DP, et al. The involvement of nurses in reporting suspected adverse drug reactions: experience with the meningococcal vaccination scheme. Br J Clin Pharmacol 2003 Dec; 56 (6): 658-63
15. Lawrence G, Menzies R, Burgess M, et al. Surveillance of adverse events following immunisation: Australia, 2000-2002. Commun Dis Intell 2003; 27 (3): 307-23
16. Zhou W, Pool V, Iskander JK, et al. Surveillance for safety after immunization: Vaccine Adverse Event Reporting System (VAERS): United States, 1991-2001. MMWR Surveill Summ 2003 Jan 24; 52(1): 1-24
17. Geier D, Geier M. Clinical implications of endotoxin concentrations in vaccines. Ann Pharmacother 2002; 36: 776-80
18. Lloyd JC, Haber P, VAERS Working Group, et al. Adverse event reporting rates following tetanus-diphtheria and tetanus toxoid vaccinations: data from the Vaccine Adverse Event Reporting System (VAERS), 1991-1997. Vaccine 2003 Sep 8; 21 (25-26): 3746-50
19. Mansoor O, Pillans PI. Vaccine adverse events reported in New Zealand 1990-5. N Z Med J 1997 Jul 25; 110 (1048): 270-2
20. D'Souza RM, Campbell-Lloyd S, Isaacs D, et al. Adverse events following immunisation associated with the 1998 Australian Measles Control Campaign. Commun Dis Intell 2000 Feb 17; 24 (2): 27-33
21. The European Agency for the Evaluation of Medical Products. Post-authorization evaluation of medicines for human use. EMEA reviews hexavalent vaccines: Hexavac and Infanrix Hexa. EMEA/8519/03. The European Agency for the Evaluation of Medical Products, London 2003
22. Hall M, McCormack P, Arthurs N, et al. The spontaneous reporting of adverse drug reactions by nurses. Br J Clin Pharmacol 1995 Aug; 40 (2): 173-5
23. Morrison-Griffiths S, Walley TJ, Park BK, et al. Reporting of adverse drug reactions by nurses. Lancet 2003 Apr 19; 361 (9366): 1347-8
24. Hunt JM, Gjoka G. Nurse reporting of adverse events caused by medicines. Nurs Times 2003 Dec 9-15; 99 (49): 24-5